Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OsrHSA in hepatic cirrhosis with hypoalbuminemia
NCT06355479Phase 3Completed
- Sponsor
- Wuhan Healthgen Biotechnology Corp.
- Start
- Apr 2023
- Primary completion
- Nov 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of OsrHSA in hypoalbuminemia, sponsored by Wuhan Healthgen Biotechnology Corp.. Started Apr 2023; status: completed.
02
Drugs
OsrHSA
03
Conditions
hypoalbuminemia
Beyond the preview
Go deeper on NCT06355479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06355479.